Skip to main content

lasofoxifene

Generic: lasofoxifene·Code: ELAINE-1, ELAINE-2, ELAINE-3

lasofoxifene: sourced relationships with 1 company · 1 clinical trial tracked.

lasofoxifene evidence translation

What we can confirm

1 tracked trial

What it means

Source-backed records connect lasofoxifene to LONA; that link alone does not prove the drug works.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

How could lasofoxifene → LONA affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (1)
CompanyDated record stage
LeonaBio, Inc. (LONA)
developer · Reported 2026-03-31 · Current development: unknownSource
Phase 3
Clinical Trial Registry Records (1)

A Double-blind, Randomized, Placebo-controlled Proof oF Concept Clinical Study to Evaluate the Safety, Pharmacokinetics, AND Pharmacodynamics of Vaginal AZU-101 (Lasofoxifene Tartrate) in Postmenopausal Women

NCT06197568Registry updated 2026-05-22·Phase 2
Recruiting

Primary endpoint: Number of Participants Who Had Any Serious Adverse Events or Any Treatment Emergent Adverse Events With Severity Greater Than "Moderate" as measured by CTCAE v4.0

InterventionalRandomizedtriple90 targetStarted 2026-06Completion 2027-061 site · United StatesAzure Biotech Inc.

Frequently asked questions

Which companies have sourced relationships with lasofoxifene?

lasofoxifene has dated SEC/FDA relationship records for LeonaBio, Inc..

How many clinical trials involve lasofoxifene?

BioSniper tracks 1 clinical trial involving lasofoxifene.